Seclo 40 Capsule
by Square Pharmaceuticals Limited
৳9.00
Probitor 40
Novartis(Bangladesh) Limited
1 Pc
৳10.10
1 Strip = 4 Pcs
৳40.40
1 Box = 10 Strips
৳404.00
Dosage: Omeprazole 40mg
Form: Capsule
Generic name(s): Omeprazole 40mg
Available (pcs): 0
Prescription required: No
PROBITOR 40 MG | Novartis Bangladesh | Order Online - OsudPotro
Generic
Omeprazole
Indications
Omeprazole is indicated for the treatment of
- Stomach and duodenal ulcers
- NSAID-associated gastric and duodenal ulcers
- For prophylaxis in patients with a history of NSAID-associated gastric and duodenal ulcers
- Gastroesophageal reflux Stomach and esophagus
- Long-term acid reflux treatment
- Acid indigestion
- Severe ulcerative reflux esophagitis
- Acid aspiration prophylaxis under general anesthesia
- Zollinger-Ellison syndrome
- Helicobacter pylori gastritis cause.
Pharmacology
Omeprazole, a substituted benzimidazole, is an inhibitor of gastric acid secretion. It inhibits gastric acid secretion by blocking the hydropotassiumadenosine triphosphatase (H + / K + ATPase) enzyme system in the parietal cells of the stomach. After oral administration, the antisecretory effect begins to occur within an hour, with maximum effect occurring within two hours and inhibition of secretion lasting up to 72 hours. When the drug is stopped, the secretory activity returns gradually, over 3 to 5 days.
Dosage
Oral-
- Benign gastric and duodenal ulcer: 20 mg once daily for 4 weeks in duodenal ulceration, 8 weeks in gastric ulceration; in severe or recurrent cases, dose to be increased to 40 mg daily; maintenance dose for recurrent duodenal ulcer, 20 mg once daily; in prevention of relapse in duodenal ulcer, 10-20 mg daily.
- NSAID-associated duodenal or gastric ulcer: 20 mg once daily for 4 weeks, continued for further 4 weeks, if not fully healed. 20 mg once daily is used as prophylaxis in patients with a history of NSAID-associated duodenal or gastric ulcers.
- Gastro-esophageal reflux disease: 20 mg once daily for 4 weeks, continued for further 4-8 weeks, if not fully healed; 40 mg once daily has been given for 8 weeks in gastro-esophageal reflux disease, refractory to other treatment; maintenance dose is 20 mg once daily.
- Long-term management of acid reflux disease: 10-20 mg daily.
- Acid-related dyspepsia: 10-20 mg once daily for 2-4 weeks.
- Prophylaxis of acid aspiration: 40 mg on the preceding evening, then 40 mg 2-6 hours before surgery.
- Zollinger-Ellison syndrome: Initially 60 mg once daily; usual range 20-120 mg daily (If daily dose is more than 80 mg, 2 divided dose should be used).
- Helicobacter pylori eradication regimen in peptic ulcer disease: Omeprazole is recommended at a dose of 20 mg twice daily in association with antimicrobial agents as detailed below: Amoxicillin 500 mg and Metronidazole 400 mg both three times a day for one week, or Clarithromycin 250 mg and Metronidazole 400 mg both twice a day for one week, or Amoxicillin 1 g and Clarithromycin 500 mg both twice a day for one week.
- Paeditaric use in severe ulcerating reflux esophagitis (Child>1 year): If body-weight 10-20 kg, 10-20 -mg once daily for 4-12 weeks; if body-weight over 20 kg, 20-40 mg once daily for 4-12 weeks.
IV Injection-
- Prophylaxis of acid aspiration: Omeprazole 40 mg to be given slowly (over a period of 5 minutes) as an intravenous injection, one hour before surgery.
- Duodenal ulcer, gastric ulcer or reflux oesophagitis: In patients with duodenal ulcer, gastric ulcer or reflux oesophagitis where oral medication is inappropriate, Omeprazole IV 40 mg once daily is recommended.
- Zollinger- Ellison syndrome (ZES): In patients with Zollinger-Ellison Syndrome the recommended initial dose of Omeprazole given intravenously is 60 mg daily. Higher daily doses may be required and the dose should be adjusted individually. When doses exceed 60 mg daily, the dose should be divided & given twice daily.
Administration
Direction for use of IV Injection: Omeprazole lyophilized powder and water for injection is for intravenous administration only and must not be given by any other route. Omeprazole IV injection should be given as a slow intravenous injection. The solution for IV injection is obtained by adding 10 ml water for injection to the vial containing powder. After reconstitution the injection should be given slowly over a period of at least 2 to 5 minutes at a maximum rate of 4 ml/minute. Use only freshly prepared solution. The solution should be used within 4 hours of reconstitution.
Direction for use of IV Infusion: Omeprazole IV infusion should be given as an intravenous infusion over a period of 20-30 minutes or more. The contents of one vial must be dissolved in 100 ml saline for infusion or 100 ml 5% Dextrose for infusion. The solution should be used within 12 hours when Omeprazole is dissolved in saline and within 6 hours when dissolved in 5% Dextrose. The reconstituted solution should not be mixed or co-administered in the same infusion set with any other drug.
Interaction
Omeprazole may prolong the elimination of diazepam, warfarin and phenytoin. Therefore, it may be necessary to reduce the dose of warfarin or phenytoin when adding omeprazole to therapy. There is no evidence of an interaction of omeprazole with theophylline, propranolol or antacids.
Contraindications
Omeprazole is contraindicated in patients with hypersensitivity to any component of the formulation.
Side Effects
Omeprazole is generally well tolerated. Nausea, abdominal pain, paraesthesia, dizziness, and headache are generally believed to be mild and transient and do not require dose reduction.
Pregnancy & Lactation
The US FDA pregnancy category omeprazole is C. However, the results of three prospective epidemiological studies did not indicate any adverse effects of omeprazole on pregnancy or on fetal health. pediatric/infant. There is no information on the passage of omeprazole in breast milk or its effects on the infant. Therefore, breastfeeding should be discontinued if the use of omeprazole is deemed necessary.
Precautions & Warnings
When a gastric ulcer is suspected, the possibility of gastric malignancy should be excluded before initiating treatment with omeprazole, as treatment may alleviate symptoms and delay diagnosis.
Therapeutic Class
Proton Pump Inhibitor.
Storage Conditions
Store at a temperature not exceeding 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.
Pharmaceuticals name
Novartis (Bangladesh) Limited.
